|
J Biol Chem, Vol. 275, Issue 10, 6733-6740, March 10, 2000
T Cells Activated by Zwitterionic Molecules Prevent Abscesses
Induced by Pathogenic Bacteria*
Arthur O.
Tzianabos §¶,
Robert W.
Finberg ,
Ying
Wang §,
Melvin
Chan ,
Andrew B.
Onderdonk **,
Harold J.
Jennings , and
Dennis L.
Kasper §§§
From the Channing Laboratory, Brigham and Women's
Hospital, Departments of § Medicine, ** Pathology,
and §§ Microbiology and Molecular Genetics,
Division of Infectious Disease, Dana Farber Cancer
Institute, Harvard Medical School Boston, Massachusetts 02115 and the
 Institute for Biological Sciences, National Research
Council of Canada, Ottawa, Ontario, K1A 0R6 Canada
 |
ABSTRACT |
Immunologic paradigms classify bacterial
polysaccharides as T cell-independent antigens. However, these models
fail to explain how zwitterionic polysaccharides (Zps) confer
protection against intraabdominal abscess formation in a T
cell-dependent manner. Here, we demonstrate that Zps elicit
a potent CD4+ T cell response in vitro that requires
available major histocompatibility complex class II molecules on
antigen-presenting cells. Specific chemical modifications to Zps show
that: 1) the activity is specific for carbohydrate structure, and 2)
the proliferative response depends upon free amino and carboxyl groups
on the repeating units of these polysaccharides. Peptides synthesized
to mimic the zwitterionic charge motif associated with Zps also
exhibited these biologic properties. Lysine-aspartic acid (KD) peptides
with more than 15 repeating units stimulated CD4+ T cells in
vitro and conferred protection against abscesses induced by
bacteria such as Bacteroides fragilis and
Staphylococcus aureus. Evidence for the biologic importance
of T cell activation by these zwitterionic polymers was provided when
human CD4+ T cells stimulated with these molecules in vitro
and adoptively transferred to rats in vivo conferred protection against intraabdominal abscesses induced by viable bacterial
challenge. These studies demonstrate that bacterial polysaccharides
with a distinct charge motif activate T cells and that this activity
confers immunity to a distinct pathologic response to bacterial infection.
 |
INTRODUCTION |
The study of T cell recognition of foreign antigens has been
directed primarily toward an understanding of the host's immune system
response to proteins or peptides. The recent demonstration that
non-peptide-containing mycobacterial lipid and glycolipid antigens
activate T cells in conjunction with CD1 molecules on the surface of
antigen-presenting cells
(APCs)1 has broadened our
understanding of antigens capable of T cell recognition (1-3). In
those studies, the carbohydrate component of mycobacterial glycolipids
was, in part, responsible for influencing T cell responses. This
observation supported earlier work in which T cell recognition of
glycoproteins was shown to be dependent on the content and distribution
of sugar residues in these structures (4-8). However, purified
carbohydrates and polysaccharides devoid of associated lipids and
proteins did not elicit proliferative responses from T cells.
The Gram-negative anaerobe Bacteroides fragilis is the most
common bacterial isolate from intraabdominal abscesses in humans (9,
10). In a rat model simulating human intraabdominal sepsis, B. fragilis, but not other anaerobic bacterial species, has the distinct ability to induce abscesses when implanted into the peritoneal cavities of animals (11-14). Anaerobic species other than B. fragilis require co-administration with a facultative organism to
induce abscesses. Recently, we have shown that prophylactic or
therapeutic subcutaneous administration of a capsular polysaccharide
from this organism, PSA, aborts the formation of intraabdominal
abscesses in rats challenged with B. fragilis or other
intestinal bacteria capable of synergistically stimulating abscess
formation (15). Studies aimed at understanding the cellular basis of
protection against abscess formation demonstrated that splenic T cells
obtained from PSA-treated animals confer protection when transferred to animals challenged with these abscess-inducing bacteria (15, 16). These
studies suggested that PSA possessed novel immunomodulatory properties
affecting T cell function.
PSA is a polysaccharide composed of oligosaccharide repeating units
possessing constituent sugars with free amino and carboxyl groups (Fig.
1). The presence of oppositely charged groups on the same bacterial
polysaccharide is distinctly uncommon because most polysaccharides
contain either neutral or negatively charged groups. The presence of
the free amino and carboxyl group on the PSA repeating unit is critical
to its biologic function. Specific chemical neutralization of either of
these charged substituents abrogates its ability to protect against
abscess formation in animals (16).
The ability of B. fragilis PSA to elicit a protective host
response that is dependent on T cells suggested an interaction between
PSA and this cell type. In this study, we present defined chemical
evidence that Zps are able to activate T cells. Proof that it is the
charge motif that is critical for this activity was provided when
chemical elimination of the charged group on the polysaccharide
resulted in failure of these molecules to activate T cells.
Furthermore, similarly charged microbial polysaccharides or peptides
synthesized to mimic the charge motif of Zps activated T cells in
vitro, and this interaction was functionally important in
protection against abscess formation.
 |
EXPERIMENTAL PROCEDURES |
Polysaccharide Preparations--
PSA was prepared from B. fragilis as described previously (17, 18). PSA used for
proliferation experiments was subjected to isoelectric focusing in a
Rotofor apparatus (Bio-Rad) to obtain the molecule in a disaggregated
state (17). Following this procedure, the preparation was dialyzed
against deionized water to remove ampholyte, lyophilized, and stored in
3 M NaCl to prevent aggregation. For some experiments, PSA
was chemically modified to assess the role of structure on T cell
activation. All modifications are shown in Fig.
1. Treatment with acetic anhydride was
used to convert all free amino groups on Sugar 1 to N-acetyl
groups (Modification I) as described previously (18). In addition, the
saccharide was treated with 37% formaldehyde in the presence of sodium
cyanoborohydride in order to convert the free amino group on PSA
repeating unit to a tertiary dimethylamine such that it retained a
positive charge (Sugar 1, Modication II). This conversion was confirmed
by NMR spectroscopy, as evidenced by the resonance at 2.9 ppm (singlet) arising from the methyl protons of the dimethylamine. The negatively charged carboxyl groups associated with the pyruvate substituent were
reduced by carbodiimide-mediated reduction (Sugar 3, Modification III)
(18). The pyruvate ring was also removed by treatment with 5% acetic
acid at 80 °C for 1 h (Sugar 3, Modification IV). The loss of
the pyruvate group was confirmed by proton NMR in which a signal at 1.5 ppm due to the methyl proton of the pyruvate group disappeared after
treatment. NMR analysis also revealed that other components of the PSA
repeating unit were not affected by this treatment.

View larger version (19K):
[in this window]
[in a new window]
|
Fig. 1.
Fine structure of B. fragilis PSA. This polysaccharide is composed of
approximately 200 tetrasaccharide repeating units and possesses free
amino, N-acetyl, and carboxyl groups. Modifications to the
PSA structure (I-VI) are described under "Experimental
Procedures."
|
|
In order to demonstrate the specificity of T cell activation by PSA,
this polymer was chemically oxidized with sodium metaperiodate (NaIO4) as described previously (19). This chemical
treatment selectively cleaves the C-C bond between vicinal hydroxyl
groups found on carbohydrates. In the case of PSA, periodate oxidation (0.01 M NaIO4 for 90 min at room temperature)
specifically cleaves C-6 from the galactofuranose side-chain (Sugar 4, Modification V), leaving an aldehyde group (CHO) at C-5. Subsequent
modification of the oxidized PSA involved reduction with sodium
borohydride (NaBH4) to reduce the aldehyde at C-5 to a
hydroxymethyl group (Sugar 4, Modification VI) that converts the
galactofuranose side-chain to arabinofuranose. Hydrolysis of this
polysaccharide with 4 M trifluoroacetic acid for 2 h
at 125 °C and subsequent analysis by gas chromatography-mass
spectrometry of the resultant alditol acetate derivative demonstrated
that >95% of the galactofuranose residues had been converted to
arabinofuranose upon oxidation and reduction. PSA was treated with 30%
hydrogen peroxide (2 h at room temperature), which oxidizes
thiol-containing amino acids to sulfone derivatives but does not affect
carbohydrate structure. All structural analyses of PSA and chemical
modifications thereof were confirmed by NMR spectroscopy.
The Streptococcus pneumoniae type 1 and type 3 capsular
polysaccharides (CPs) were obtained from the ATCC (Manassas, VA) and treated with 2 M NaOH for 1 h at 80 °C to remove
the contaminating cell wall polysaccharide, C substance. Following
purification by gel filtration chromatography, the S. pneumoniae polysaccharides were subjected to isoelectric focusing,
dialyzed, lyophilized, and stored in 3 M NaCl to prevent
aggregation. The free amino group of the type 1 CP was chemically
modified in two separate experiments. This group was converted to an
N-acetyl moiety by treatment with acetic anhydride or
converted to a tertiary amine by treatment with formaldehyde in the
presence of sodium cyanoborohydride as described above for PSA. These
chemical modifications were confirmed by NMR spectroscopy as described
above. -Glucan (Alpha-Beta Technology, Worcestor, MA) was used as a
negative polysaccharide control for some studies.
Preparation of Peptides--
Peptides (KD)n were
synthesized on a Rainin Symphony peptide synthesizer. Peptides were
prepared with 4-alkoxybenzyl alcohol resins (PerSeptive Biosystems
Inc., Framingham, MA) using Fmoc chemistry. Amino acids were activated
with 2-(1H-benzotriazole-1-yl)-1,1,3,3 tetramethyluronium
hexafluorophosphate for coupling. The peptides prepared were analyzed
by matrix-assisted laser desorption ionization-time of flight mass
spectrometry and NMR spectroscopy. Mass spectra were acquired on a
Voyager matrix-assisted laser desorption ionization-time of flight mass
spectrometer. Proton NMR spectra were acquired on a Bruker AMX500
instrument with proton frequency of 500 MHz. Both analyses confirmed
that the peptides were the expected structures. Preparations of
poly-L-lysine with molecular masses ranging from 1000 to
4000 daltons were obtained commercially (Sigma). All peptides were
subjected to isoelectric focusing as described above.
T Cell Proliferation Assay--
T cell proliferation assays were
performed on cells obtained from human leukopacs (discarded white cells
from anonymous platelet donors) as described previously (20, 21).
Mononuclear cells were separated by Ficoll-Hypaque sedimentation to
eliminate red cells and polymorphonuclear leukocytes. The mononuclear
layer, which consisted of T cells, B cells, and mononuclear cells was depleted of B cells and monocytes by passage over nylon wool column. A
portion of these cells was saved prior to placement on nylon wool and
used as autologous feeder cells following irradiation with 6.4 krad
with a cesium source for 4.8 min. Nylon-passed cells, which were more
than 98% CD3-positive (as determined by fluorescence-activated cell
sorter analysis), were used as responder cells or further depleted with
antibodies to CD4 (OKT4) or CD8 (OKT8) followed by negative selection
with magnetic beads as described (20, 21). Responder cells (5 × 104 cells/well) were added to 2.5 × 105
irradiated feeder cells and cultured in U-bottomed 96-well plates (Corning-Costar Corp., Cambridge, MA) with RPMI 1640 and 5% fetal calf
serum. At predetermined time points, cells were pulsed with 1 µCi of
[3H]thymidine/well 6 h prior to harvest in order to
measure cell proliferation. Cells were washed extensively and
harvested, and the amount of radioactive uptake was counted by liquid
scintillation. Data were expressed as the average of triplicate
wells ± the S.D. of cpm represented. For all proliferation
experiments, data represent typical results from at least five
different experiments. For antibody blocking experiments, T cells and
APCs were mixed with LB3.1 (20 µg/ml), a class II specific monoclonal
antibody (anti-DR) for 20 min at 37 °C. An isotype matched
monoclonal antibody, 5E2B4, was added to cultures as an irrelevant
control. Following incubation with antibody, S. pneumoniae
type 1 CP was added (20 µg/ml) and allowed to incubate for 6 days, at
which time proliferation was assessed as described above.
Animal Model of Intraabdominal Abscess Formation--
The rat
model of intraabdominal sepsis developed by Onderdonk was used (22).
Male Lewis rats (180-200 g, Charles River Laboratories, Wilmington,
MA) were used for all experiments. Animals were housed separately and
received chow (Ralston Purina, St. Louis, MO) and water ad
libitum. Animals were anesthetized with a single intraperitoneal injection of 0.15 ml of Nembutal (50 mg/ml, Abbott Laboratories, North
Chicago, IL), and their abdomens were shaved and swabbed with a
tincture of iodine. An anterior midline incision (1 cm) was made
through the abdominal wall and peritoneum, and a gelatin capsule
containing 0.5 ml of inoculum was inserted into the pelvis. The
incisions were closed with interrupted 3.0 silk sutures, and the
animals were returned to the cages. The inoculum contained a 1:1
mixture of B. fragilis NCTC 9343 (108
cfu/animal) or S. aureus PS 80 (107 cfu/animal,
a kind gift from Dr. Jean Lee, Channing Laboratory, Harvard Medical
School) and an adjuvant solution containing sterile rat cecal contents
and 10% barium sulfate (w/v). Six days later, animals were necropsied
in a blinded fashion and examined for the formation of one or more
intraabdominal abscesses. Animal care was in accordance with the
institutional guidelines set forth by Brigham and Women's Hospital and
Harvard Medical School.
T Cell Transfer Studies--
Cell transfer experiments were
performed as described previously (15). Human CD4+ T cells were
purified as described above and cultured in vitro with
irradiated APCs in the presence of PSA or KD20 (20 µg/ml)
for 5 days. T cells were harvested, examined for viability by trypan
blue exclusion, and further enriched by passage over nylon wool (more
than 95% pure CD4+ T cells as assessed by fluorescence-activated cell
sorter analysis). Purified T cells were then counted and adjusted to an
appropriate cell number (3 × 106/animal) prior to
intracardiac transfer to animals (0.2 ml). Animals were challenged with
B. fragilis 24 h later and assessed for abscess formation 6 days later.
Statistical Analyses--
Comparison of abscess formation
between groups of animals was made by 2 analysis,
whereas comparison of groups in T cell proliferation assays was made by
Student's t test (InStat, GraphPad Software, Inc., San
Diego CA).
 |
RESULTS |
PSA Stimulates Human T Cell Activation--
In proliferation
assays with human T cells, PSA elicited a dose-dependent
response (dose range, 10-0.1 µg/ml; Fig.
2A). This proliferative
response peaked 6 days after culture with PSA. When tested at an
optimal concentration of 1 ng/ml, the proliferative response to
staphylococcal enterotoxin A also peaked at day 6 (Fig. 2). The
depletion of T cells from these preparations abrogated the
proliferative activity, whereas depletion of B cells did not (data not
shown).

View larger version (14K):
[in this window]
[in a new window]
|
Fig. 2.
T cell activation by B. fragilis
PSA and modified PSA derivatives. A, 10-fold
dilutions of PSA were co-cultured with human T cells (5 × 104 cells/200 µl) and irradiated APCs (2.5 × 105/200 µl) (17, 18) for 6 days.
[3H]Thymidine (1 µCi/well) was added during the last
6 h of culture. The response to PSA was dose-dependent
and peaked 6 days after culture. The response to PSA typically varied
with human T cell donors. In all assays, irradiated APCs cultured with
PSA or staphylococcal enterotoxin A (SEA) alone did not
proliferate in response to these antigens. The results shown are
representative of at least five independent experiments. B,
PSA was chemically N-acetylated by treatment with acetic
anhydride as described in Fig. 1, Modification I. Conversion
of the free amino groups of PSA to N-acetyl groups abrogated
the proliferative response. Reduction of the negatively charged
carboxyl group associated with the pyruvate ketal ring of the terminal
galactose residue (Fig. 1, Modification III) reduced the
proliferative response by 72%. PSA was subjected to selective
oxidation by treatment with 0.01 M sodium metaperiodate
(Fig. 1, Modification V). Oxidation by this method abrogated
T cell activation by this polysaccharide (PSA: oxidized
(NaIO4)). However, upon reduction of the oxidized PSA with
NaBH4 (Fig. 1, Modification VI), the
proliferative response to PSA was regenerated (PSA:
oxidized/reduced). T cell proliferation assays revealed that the
peroxide-treated PSA yielded activity equivalent to that of the
untreated polysaccharide (PSA versus PSA:
peroxide). Demonstration of comparable proliferative activity by
the peroxide-oxidized PSA and regeneration of the proliferative
activity of the periodate-oxidized and reduced PSA confirmed that the
observed T cell response is attributable to the polysaccharide and not
to a contaminating protein. All polysaccharides were tested at a
concentration of 10 µg/ml. CD4+ T cells were used as the responder
cell in these experiments.
|
|
In previous studies, we have demonstrated the importance of the free
amino group at C-4 of the
2-acetamido-4-amino-2,4,6-trideoxygalactose residue of PSA
(Fig. 1, Sugar 1) and the carboxyl group associated with the
pyruvate group on Sugar 3 in mediating in vivo biologic functions (14, 16, 23). In light of these data, we assessed the role of
these chemical groups on T cell activation by PSA. A specific chemical
modification converted the free amino groups on PSA to
N-acetyl groups (Fig. 1, Sugar 1, Modification
I). N-Acetylation of PSA abrogated T cell activation by
PSA, a result indicating that free amino groups on PSA are critical for
T cell activation (Fig. 2B, PSA versus PSA: NAc).
Furthermore, conversion of this group to a tertiary amine that still
retains its positive charge ( HN+(CH3)2) by treatment with an
aldehyde group under reducing conditions (as shown in Fig. 1,
Modification II) significantly reduced T cell proliferation
(medium control = 1123 ± 510 cpm; PSA = 11,215 ± 763 cpm; formaldehyde-treated PSA = 1256 ± 439 cpm).
Chemical modification of the carboxyl group associated with the
pyruvate substituent on PSA via carbodiimide-mediated reduction (Fig.
1, Sugar 3, Modification III) resulted in a 72% decrease in
the proliferative response as compared with the unmodified PSA (tested
at 20 µg/ml, 7937 ± 3264 cpm versus 27,886 ± 7890 cpm, respectively). This finding was supported by experiments in
which the pyruvate ring was completely removed by acid hydrolysis (Fig.
1, Sugar 3, Modification IV), resulting in complete
abrogation of the proliferative effect (medium = 750 ± 375 cpm; PSA (20 µg/ml) = 25,714 ± 1429; acid-treated PSA (20 µg/ml) = 552 ± 171 cpm).
Specificity of T Cell Activation by PSA--
We have carefully
considered the possibility that the T cell proliferative response to
PSA could reflect the presence of protein or peptide contamination. The
following data specifically address this issue. 1) Purification of
surface polysaccharides from B. fragilis involved procedures
designed to degrade or denature proteins (extraction with hot phenol,
repeated Pronase digestion, and boiling in 1M NaOH for 1 h) (24).
2) SDS-polyacrylamide gel electrophoresis, quantitative protein assays,
and amino acid analysis reflected the absence of protein in
polysaccharide samples. 3) Due to its charge motif, PSA ionically
aggregates in aqueous solution, causing PSA to lose its ability to
stimulate T cell proliferation. It is necessary to disaggregate this
ionic complex via isoelectric focusing shortly before use for T cell
activation to occur (data not shown). 4) Chemical treatment of PSA,
which specifically alters carbohydrates but not proteins, abrogated
proliferation by PSA. However, chemical regeneration of the affected
carbohydrate groups restored T cell activation. For the last set of
experiments, PSA was chemically oxidized by sodium metaperiodate
(NaIO4) treatment, which is selective for the cleavage of
the C-C bond between vicinal hydroxyl groups on carbohydrates. In the
case of PSA, periodate oxidation is exquisitely specific for removing
the C-6 of the galactofuranose side chain (Fig. 1, Sugar 4, Modification V), creating an aldehyde group at C-5. When tested
for T cell proliferation, periodate-oxidized PSA failed to elicit a
response (Fig. 2B, PSA versus PSA: oxidized). After
periodate oxidation, PSA was reduced with NaBH4, converting
the aldehyde group at C-5 to a hydroxymethyl group (Fig. 1, Sugar
4, Modification VI). This modification resulted in the conversion
of the side-chain sugar to an arabinofuranose residue but left the
original motif of the charged groups on the polysaccharide intact. The
regeneration of the side-chain hydroxymethyl group on oxidized PSA
restored the proliferative activity of this polysaccharide (Fig.
2B, PSA versus PSA: oxidized/reduced). NMR spectroscopy and
gas chromatography-mass spectrometry confirmed that >95% of the
repeating units were modified as described.
Generally, proteins are highly resistant to NaIO4
oxidation; however, it is possible that this treatment could oxidize
thiol groups present in cysteine residues associated with proteins or peptides to sulfoxide derivatives (25). If this were the case, reduction with NaBH4 could reverse the oxidation procedure
to regenerate this affected amino acid. Therefore, the results
described above might be attributed to contamination by peptides
containing cysteines. To eliminate this remaining possibility, PSA was
treated with hydrogen peroxide, which oxidizes thiol groups on cysteine to sulfoxide derivatives (25) but does not affect carbohydrate structure. T cell proliferation assays with hydrogen peroxide-treated PSA revealed that the proliferative activity was equivalent to that of
the untreated polysaccharide (Fig. 2B, PSA versus PSA: peroxide).
T Cell Activation by the S. pneumoniae Type 1 CP--
We next
determined whether another bacterial polysaccharide with a charge motif
similar to PSA could activate T cells in vitro. S. pneumoniae type 1 CP is among the few naturally occurring
polysaccharides that have oppositely charged groups (26). The type 1 CP
is a trisaccharide repeating unit that has the same sugar residue with a positively charged free amino group
(2-acetamido-4-amino-2,4,6-trideoxygalactose residue) that
occurs in PSA, and it has two galacturonic acid residues containing
negatively charged carboxyl groups per repeating unit. In previous
studies, we have demonstrated that, like PSA, the type 1 CP also
protects animals against abscess formation (16). This protective
activity is also dependent on the presence of the free amino group on
its repeating unit structure. When tested for CD4+ T cell
proliferation, this polysaccharide (after disaggregation by isoelectric
focusing) yielded a response that peaked after 6 days of culture (Fig.
3A). T cell proliferation assays performed with S. pneumoniae type 3 capsule, which is
a disaccharide repeating unit of glucose and glucuronic acid (27) and
has only one negatively charged group per repeating unit, did not yield
a response (Fig. 3A). As demonstrated with B. fragilis PSA, N-acetylation of the type 1 CP abrogated
the proliferative response (Fig. 3B). Conversion of the free
amino group of the type 1 CP to a tertiary dimethylamine that retained
its positive charge resulted in a significant decrease in the
proliferative activity. The activity of the treated polysaccharide was
3.5 times less active than the untreated control polysaccharide (Fig.
3C, p < 0.001). These results correlated
with our findings with B. fragilis PSA in which the same
chemical treatment also resulted in loss of activity.

View larger version (12K):
[in this window]
[in a new window]
|
Fig. 3.
CD4+ T cell response to S. pneumoniae type 1 and type 3 CPs. A,
comparison of T cell proliferation by the type 1 CP compared with the
type 3 CP. The type 3 CP consists of a repeating unit of glucose and
glucuronic acid and did not elicit a T cell response in these assays.
B, dose response and effect of N-acetylation of
the S. pneumoniae type 1 CP. The type 1 CP elicited a potent
T cell response that was typically 60-70% of the PSA response in this
assay. N-Acetylation of type 1 capsular polysaccharide
abrogated T cell proliferation. This modification was confirmed by NMR
spectroscopy. C, effect of formaldehyde treatment on T cell
activation by S. pneumoniae type 1 CP. Conversion of the
free amino group on this polymer to a tertiary amine that retains its
positive charge significantly reduced its ability to stimulate T cells
(p < 0.001 compared with the untreated control,
Student's t test).
|
|
T Cell Activation by Synthetic Zwitterionic Peptides--
In order
to demonstrate the role of the zwitterionic charge motif in T cell
activation, a dipeptide repeating unit was synthesized to mimic the
repeating unit structure of PSA. For this purpose, different repeating
unit sizes of lysine and aspartic acid were synthesized and tested for
their ability to stimulate CD4+ T cells. KD peptides consisting of 15, 20, or 25 repeating units each stimulated T cell activation in
vitro (Fig. 4). However, peptides
consisting of less than 15 repeating units (1, 5, and 10 repeats) did
not stimulate T cell activation. Testing of a peptide with positively charged groups only, poly-L-lysine, did not stimulate T
cell proliferation (data not shown). These data clearly indicate that
zwitterionic repeating unit polymers other than polysaccharides
stimulate T cell activation and that this activity depends on the
repeating unit size of the polymer.

View larger version (30K):
[in this window]
[in a new window]
|
Fig. 4.
Effect of repeating unit size on CD4+ T cell
proliferation. KD peptides (20 µg/ml) of varying size were
assessed for their ability to stimulate T cell activation 6 days
postincubation. Culture of polymers consisting of 15, 20, or 25 repeats
with T cells and APCs resulted in T cell proliferation. Incubation with
peptides with 1, 5 or 10 repeats did not stimulate T cell activation.
The S. pneumoniae type 1 CP (20 µg/ml) was included as a
positive control.
|
|
Protection against Abscess Formation by Zwitterionic
Peptides--
We next investigated whether these peptides could
protect animals against abscess formation in vivo. Animals
were administered 50 or 5 µg of the 25-repeating-unit KD peptide and
challenged with B. fragilis. The results are shown in Table
I, Experiment A. Treatment with the
higher dose of (KD)25 yielded significant protection in
animals compared with the saline-treated control group (17% compared
with 78%, respectively; p < 0.0005). However, treatment with the lower dose of the peptide failed to protect. S. pneumoniae type 1 CP yielded significant protection of
animals at the 50-µg dose but not at the 5-µg dose. Administration
of poly-L-lysine at the higher dose did not protect against
abscess formation. Finally, treatment of animals with
(KD)25 protected animals against intraabdominal abscess
formation by S. aureus (Table I, Experiment B). Animals
treated with saline and challenged with S. aureus had a 80%
abscess rate, whereas treatment with 50 µg of (KD)25
reduced abscess formation to 20% (p < 0.02).
The effect of the peptide repeating unit size on protection was
examined. Animals were treated according to the regimen described above
with a 50 µg/dose of each repeating unit size (Table
II). Treatment with the 15-, 20-, or
25-repeating-unit peptide resulted in a significant level of
protection. However, treatment with peptide repeating units less than
15 repeats did not yield significant protection compared with animals
treated with saline. In fact, for peptides of less than 15 repeats, the
level of protection diminished as the repeating unit size
decreased.
Characterization of T Cell Response to PSA--
Characterization
of the T cell response to PSA demonstrated that CD4+ T cells were
preferentially activated. In tritiated thymidine uptake assays
performed on T cell populations, the CD4+ T cell response was
comparable to the CD3+ response and 2.4 times greater than the CD8+ T
cell response (Fig. 5A).
Incubation of CD4+ T cells with PSA in the absence of irradiated feeder
cells failed to elicit proliferation, thereby establishing the
requirement for APCs in this system (Fig. 5B). In initial
experiments, depletion of MHC class II-bearing cells (by negative
selection with the class II specific antibody LB3.1) abrogated the
proliferative activity of PSA (data not shown). In further experiments,
preincubation of irradiated APCs with LB 3.1 inhibited T cell
activation by PSA (Fig. 5C), whereas incubation of an
isotype matched antibody (5E2B4) with APCs did not have this effect.
The loss of activity following antibody blockade of MHC class II
molecules suggested that available class II molecules are required for
PSA-mediated T cell activation.

View larger version (15K):
[in this window]
[in a new window]
|
Fig. 5.
Characterization of T cell response to
PSA. A, phenotypic T cell response to PSA. Culture of
PSA with unfractionated T cells (CD3+) or CD4+ cells yielded similar
proliferative responses. However, the response of CD8+ cells to PSA in
this assay was 2.4-fold less than that of CD4+ cells at the highest
dose tested (20 µg/ml). B, requirement for APCs. Ten-fold
dilutions of PSA were cultured with purified CD4+ cells alone or CD4+
cells mixed with irradiated APCs. Culture of PSA with CD4+ cells in the
absence of irradiated APCs failed to elicit any proliferative response.
Culture of PSA with both CD4+ cells and APCs yielded a
dose-dependent response in these assays. C,
blocking of T cell proliferation by MHC class II-specific antibody.
Incubation with LB3.1 inhibited proliferation of T cells in response to
S. pneumoniae type 1 CP. Incubation with 5E2B4 did not
inhibit this response, yielding a proliferation level comparable to the
medium control.
|
|
Biologic Role for T Cell Activation by Zps and Zwitterionic
Peptides--
To assess the biologic function of T cells stimulated by
these polymers, in vitro-stimulated human CD4+ T cells were
transferred to rats and challenged with an abscess-inducing bacterial
inoculum in the animal model described above. T cells were cultured
in vitro with PSA (20 µg/ml) or an irrelevant
polysaccharide ( -glucan) for 5 days and transferred to rats via the
intracardiac route. The following day, animals were challenged with
B. fragilis, and they were examined 6 days later for the
presence of intraabdominal abscesses. Results are shown in Table
III, Experiment A. Animals receiving CD4+
T cells stimulated in vitro with PSA showed a significant reduction in abscess formation compared with animals receiving T cells
cultured in medium only (9% versus 76% abscess rate,
respectively; p < 0.0001). T cells cultured with a
glucan polymer ( -glucan) did not confer protection (79% abscess
rate). Similar studies with KD20 were performed (Table III,
Experiment B). The number of animals given T cells cultured with 20 µg/ml of this peptide was significantly lower than those given T
cells stimulated with medium (10% compared with 90%;
p < 0.002). T cells stimulated with
poly-L-lysine yielded an 80% abscess rate in recipient
animals.
 |
DISCUSSION |
Previous studies have indicated that polysaccharide antigens
elicit T cell-mediated immune responses. For example, different T cell
subsets can regulate the magnitude of antibody responses to specific
pneumococcal and meningococcal polysaccharides (28, 29), and
cell-mediated immunity plays a distinct role in the host response to
the Pseudomonas aeruginosa capsular polysaccharide (30).
Furthermore, models of nonpeptide antigen recognition by T cells
advanced by a series of in vitro studies with mycobacterial antigens has augmented the evidence that T cells are important in the
immunosurveillance of foreign antigens other than proteins (1-3, 31,
32). More recently, a putative carbohydrate antigen derived from a
pollen allergen has been shown to stimulate CD8+ T cells in
vitro (33). The structural characterization of this antigen and
the relevance to in vivo host responses is unknown.
Results from the present study show that highly purified microbial
polysaccharide antigens that possess free amino and negatively charged
groups stimulate human CD4+ T cell activation. We performed a series of
chemical modifications of PSA to demonstrate that the observed T cell
proliferation is specific for carbohydrate structure. Loss of this
activity following periodate oxidation is likely due to the generation
of aldehydes following periodate oxidation that interact with free
amino groups on PSA to form intermediate Schiff bases. The occupation
of free amino groups with intra- and/or intermolecular aldehydes in
Schiff base formation rather than in the interaction with T cells
and/or APCs may have resulted in the lack of proliferation by the
oxidized form of PSA. Rhodes and co-workers (34) have shown that Schiff
base formation between T cells and APCs are critical in providing
signals for T cell activation. In addition, the generation of aldehydes on PSA could allow it to interact inappropriately with serum proteins. These groups can also isomerize or form acetals under certain conditions. Demonstration of comparable proliferative activity by the
peroxide-oxidized product and recovery of proliferative activity via
NaBH4 reduction of periodate-oxidized PSA confirmed that
the observed T cell response is attributable to the carbohydrate and
not to a contaminating protein.
Chemical modifications to PSA and the S. pneumoniae type 1 CP demonstrated that positively charged free amino groups and
negatively charged groups on these polymers are required for T cell
activation. Although these saccharides possess different repeating unit
structures, the presence of these charged groups is sufficient for T
cell activation. Conversion of the free amino groups on each of these repeating unit structures to tertiary amines that retained a positive charge resulted in loss of activity. This result demonstrated that a
primary amine is necessary for activity and correlates with our
previous studies with C substance, the group polysaccharide from
S. pneumoniae. This saccharide has positively charged free amino groups (NH3+) and a trimethylamine group
( N+(CH3)3) on each repeating unit
and exhibits the same biologic activity as PSA and the S. pneumoniae type 1 CP in the animal model of intraabdominal abscess
formation. Conversion of the free amino groups to neutrally charged
N-acetyl moieties following chemical
N-acetylation did not affect the positively charged
trimethylamine group on this repeating unit and resulted in the loss of
in vivo biologic function (35).
The importance of the zwitterionic charge motif associated with Zps was
underscored by our finding that synthetically derived repeating unit
peptides designed to possess this motif also exhibit these biologic
properties. Using these molecules, we have shown that repeating unit
size is critical to their biologic function. These data clearly
demonstrate that the in vitro T cell activation results
correlate with their ability to protect animals in vivo against abscess formation and that KD peptides less than 15 repeating units long do not possess these biologic activities.
Zps preferentially stimulate CD4+ T cells and require accessory cells
to support T cell stimulation by PSA. Further study showed that
blockade of MHC class II molecules by a specific antibody on APCs
abrogated T cell activation. In addition, depletion of class II-bearing
APCs abrogated proliferation by PSA in this system. The role of the T
cell receptor in this process is currently undefined, and it is unclear
whether Zps behave as superantigens or conventional antigens. Further
studies are under way to determine the mechanism by which these
molecules activate T cells.
Previous studies have indicated that molecules possessing positively
and negatively charged groups can regulate the activity of host immune
cells. Amphoteric molecules such as copolymer I and mylein basic
protein have been described as modulating T cell function in
experimental models of autoimmune disease (36, 37). Copolymer I is a
synthetic random protein consisting of alanine, glutamic, lysine, and
tyrosine that specifically inhibits the T cell response elicited by
mylein basic protein and suppresses experimental allergic
encephalomyelitis. Copolymer I is believed to interact directly with
HLA-DR MHC class II molecules (38). Recent studies have shown that
zwitterionic glycosphingolipids exhibit immunomodulatory biologic
activities on peripheral blood mononuclear cells, as well as on T- and
B-lymphocyte populations (39-42). Lochnit et al. (41) have
shown that the ability of these molecules to activate immune cell
function is dependent upon component substituent groups (such as
phosphocholine and phosphoethanolamine) that possess both positive and
negative charges. Like Zps, the removal of these groups via chemical
modification resulted in the loss of biologic activity.
We have recently shown that PSA possesses mitogenic activity for mouse
B cells and rat T cells (43). The reason for this differential
stimulatory effect may be due to the affinity of the polysaccharide for
different receptors on lymphocytes from these two species or the
inability of T or B cells from these species to respond. In the present
study, we demonstrate that human CD4+ T cells respond preferentially to
PSA and that this activity is specific for the carbohydrate. Human B
cells did not respond to PSA. The finding that human and rat T cells
are activated by PSA is intriguing and supports our use of the rat
model to test the biologic activity of this molecule.
Importantly, the role for T cells activated by PSA and KD20
was demonstrated by their ability to prevent abscess formation in
vivo. Human T cells stimulated in vitro with these
polymers protected against abscess formation. These data provide direct evidence of the specificity of T cell activation by Zps and
KD20 with prevention of this disease process. Furthermore
these data suggest that: 1) T cells stimulated by these molecules
in vitro suppress abscess formation in animals, and 2) the
protective efficacy may be attributable to the production of a T
cell-derived cytokine(s) that exerts activity in a xenogeneic fashion.
Recently, we have shown that interleukin-2 produced by splenic T cells
of animals treated with Zps mediates protection against abscess
formation (23). The ability of Zps to activate T cells that confer this protective activity correlates with these findings. We are currently investigating the mechanisms by which interleukin-2 confers this protective effect.
In summary, these data expand the repertoire of antigens known to
stimulate T cells and ascribe a biologic function for nonpeptide activation of these lymphocytes. These studies support the concept that
polysaccharide-T cell interactions are critical to the modulation of
host immune responses to certain bacterial infections.
 |
ACKNOWLEDGEMENTS |
We thank Ronald Cisneros, Mary Delaney,
Matthew Lawlor, Pamela R. Russell, Roger Smith, Brian Hyett, and Trina
Tabacco for their contribution to this work and Drs. Gerald Pier,
Michael Wessels, and Jean Lee for critically reviewing the manuscript.
 |
FOOTNOTES |
*
This work was supported in part by NIAID, National
Institutes of Health, Grants AI 34073 and AI 39576.The costs of publication of this
article were defrayed in part by the
payment of page charges. The article
must therefore be hereby marked
"advertisement" in accordance with 18 U.S.C. Section
1734 solely to indicate this fact.
¶
To whom correspondence should be addressed: Channing
Laboratory, 181 Longwood Ave., Boston, MA 02115. Tel.: 617-525-2610; Fax: 617-731-1541; E-mail: atzianabos@channing.harvard.edu.
 |
ABBREVIATIONS |
The abbreviations used are:
APC, antigen-presenting cell;
PSA, polysaccharide A;
Zps, zwitterionic
polysaccharides;
MHC, major histocompatibility complex;
NaIO4, sodium metaperiodate;
NaBH4, sodium
borohydride;
CP, capsular polysaccharide.
 |
REFERENCES |
| 1.
|
Sieling, P. A.,
Chatterjee, D.,
Porcelli, S. A.,
Prigozy, T. I.,
Mazzaccaro, R. J.,
Soriano, T.,
Bloom, B. R.,
Brenner, M. B.,
Kronenberg, M.,
Brennan, P. J.,
and Modlin, R. L.
(1995)
Science
269,
227-230[Abstract/Free Full Text]
|
| 2.
|
Beckman, E. M.,
Porcelli, S. A.,
Morita, C. T.,
Behar, S. M.,
Furlong, S. T.,
and Brenner, M. B.
(1994)
Nature (Lond.)
372,
691-694[CrossRef][Medline]
[Order article via Infotrieve]
|
| 3.
|
Porcelli, S. A.,
Morita, C. T.,
and Brenner, M. B.
(1992)
Nature (Lond.)
360,
593-597[CrossRef][Medline]
[Order article via Infotrieve]
|
| 4.
|
Michaelsson, E.,
Malmstrom, V.,
Reis, S.,
Engstrom, A.,
Burkhardt, H.,
and Holmdahl, R.
(1994)
J. Exp. Med.
180,
745-749[Abstract/Free Full Text]
|
| 5.
|
Haurum, J. S.,
Arsequell, G.,
Lellouch, A. C.,
Wong, S. Y.,
Dwek, R. A.,
McMichael, A. J.,
and Elliott, T.
(1994)
J. Exp. Med.
180,
739-744[Abstract/Free Full Text]
|
| 6.
|
Harding, C. V.,
Kihlberg, J.,
Elosfsson, M.,
Magnusson, G.,
and Unanue, E. R.
(1993)
J. Immunol.
151,
2419-2425[Abstract]
|
| 7.
|
Harding, C. V.,
Roof, R. W.,
Allen, P. M.,
and Unanue, E. R.
(1991)
Proc. Natl. Acad. Sci. U. S. A.
88,
2740-2744[Abstract/Free Full Text]
|
| 8.
|
Ishioka, G. Y.,
Lamont, A. G.,
Thomson, D.,
Bulbow, N.,
Gaeta, F. C. A.,
Sette, A.,
and Grey, H. M.
(1992)
J. Immunol.
148,
2446-2451[Abstract]
|
| 9.
|
Gorbach, S. L.,
Thadepalli, H.,
and Norsen, J.
(1974)
Anaerobic Microorganisms in Intraabdominal Infections
, pp. 399-407, Charles C. Thomas, Springfield, Illinois
|
| 10.
|
Polk, B. J.,
and Kasper, D. L.
(1977)
Ann. Intern. Med.
86,
567-571
|
| 11.
|
Kasper, D. L.,
Hayes, M. E.,
Reinap, B. G.,
Craft, F. O.,
Onderdonk, A. B.,
and Polk, B. F.
(1977)
J. Infect. Dis.
136,
75-81[Medline]
[Order article via Infotrieve]
|
| 12.
|
Kasper, D. L.,
Onderdonk, A. B.,
Crabb, J.,
and Bartlett, J. G.
(1979)
J. Infect. Dis.
140,
724-731[Medline]
[Order article via Infotrieve]
|
| 13.
|
Onderdonk, A. B.,
Kasper, D. L.,
Cisneros, R. L.,
and Bartlett, J. G.
(1977)
J. Infect. Dis.
136,
82-89[Medline]
[Order article via Infotrieve]
|
| 14.
|
Tzianabos, A. O.,
Onderdonk, A. B.,
Rosner, B.,
Cisneros, R. L.,
and Kasper, D. L.
(1993)
Science
262,
416-419[Abstract/Free Full Text]
|
| 15.
|
Tzianabos, A. O.,
Kasper, D. L.,
Cisneros, R. L.,
Smith, R. S.,
and Onderdonk, A. B.
(1995)
J. Clin. Invest.
96,
2727-2731
|
| 16.
|
Tzianabos, A. O.,
Onderdonk, A. B.,
Zaleznik, D. F.,
Smith, R. S.,
and Kasper, D. L.
(1994)
Infect. Immun.
62,
4881-4886[Abstract/Free Full Text]
|
| 17.
|
Tzianabos, A. O.,
Pantosti, A.,
Baumann, H.,
Brisson, J. R.,
Jennings, H. J.,
and Kasper, D. L.
(1992)
J. Biol. Chem.
267,
18230-18235[Abstract/Free Full Text]
|
| 18.
|
Baumann, H.,
Tzianabos, A. O.,
Brisson, J. R.,
Kasper, D. L.,
and Jennings, H. J.
(1992)
Biochemistry
31,
4081-4089[CrossRef][Medline]
[Order article via Infotrieve]
|
| 19.
|
Paoletti, L. C.,
Kasper, D. L.,
Michon, F.,
DiFabio, J.,
Jennings, H. J.,
Tosteson, T. D.,
and Wessels, M. R.
(1992)
J. Clin. Invest.
89,
203-209
|
| 20.
|
Haregewoin, A.,
Soman, G.,
Hom, R. C.,
and Finberg, R. W.
(1989)
Nature (Lond.)
340,
309-312[CrossRef][Medline]
[Order article via Infotrieve]
|
| 21.
|
Finberg, R. W.,
White, W.,
and Nicholson-Weller, A.
(1992)
J. Immunol.
149,
2055-2060[Abstract]
|
| 22.
|
Onderdonk, A. B.,
Bartlett, J. G.,
Louie, T.,
Sullivan-Seigler, N.,
and Gorbach, S. L.
(1976)
Infect. Immun.
13,
22-26[Abstract/Free Full Text]
|
| 23.
|
Tzianabos, A. O.,
Russell, P. R.,
Onderdonk, A. B.,
Gibson, F. C., 3rd,
Cywes, C.,
Chan, M.,
Finberg, R. W.,
and Kasper, D. L.
(1999)
J. Immunol.
163,
893-897[Abstract/Free Full Text]
|
| 24.
|
Pantosti, A.,
Tzianabos, A. O.,
Onderdonk, A. B.,
and Kasper, D. L.
(1991)
Infect. Immun.
59,
2075-2082[Abstract/Free Full Text]
|
| 25.
|
March, J.
(1992)
Advances in Organic Chemistry
, 4th Ed.
, pp. 1202-1222, John Wiley & Sons, New York
|
| 26.
|
Lindberg, B.,
Lindqvist, B.,
Lonngren, J.,
and Powell, D. A.
(1980)
Carbohydr. Res.
78,
111-117[CrossRef][Medline]
[Order article via Infotrieve]
|
| 27.
|
Reeves, R. E.,
and Goebel, W. F.
(1941)
J. Biol. Chem.
139,
511-519[Free Full Text]
|
| 28.
|
Taylor, C. E.,
and Bright, R.
(1989)
Infect. Immun.
57,
180-185[Abstract/Free Full Text]
|
| 29.
|
Muller, E.,
and Apicella, M. A.
(1988)
Infect. Immun.
56,
259-266[Abstract/Free Full Text]
|
| 30.
|
Markham, R. B.,
Pier, G. B.,
Goellner, J. J.,
and Mizel, S. B.
(1985)
J. Immunol.
134,
4112-4117[Abstract]
|
| 31.
|
Mortia, C. T.,
Beckman, E. M.,
Bukowski, J. F.,
Tanaka, Y.,
Band, J.,
Bloom, B. R.,
Golan, D. E.,
and Brenner, M. B.
(1995)
Immunity
3,
495-507[CrossRef][Medline]
[Order article via Infotrieve]
|
| 32.
|
Constant, P.,
Davodeau, F.,
Peyrat, M. A.,
Poquet, Y.,
Puzo, G.,
Bonneville, M.,
and Fournie, J. J.
(1994)
Science
264,
267-270[Abstract/Free Full Text]
|
| 33.
|
Corinti, S.,
De Palma, R.,
Fontana, A.,
Gagliardi, C.,
Pini, C.,
and Sallusto, F.
(1997)
J. Exp. Med.
186,
899-908[Abstract/Free Full Text]
|
| 34.
|
Zheng, B.,
Brett, S. J.,
Tite, J. P.,
Lifely, M. R.,
Brodie, T. A.,
and Rhodes, J.
(1992)
Science
256,
1560-1563[Abstract/Free Full Text]
|
| 35.
|
Tzianabos, A. O.,
Onderdonk, A. B.,
Smith, R. S.,
and Kasper, D. L.
(1994)
Infect. Immun.
62,
3590-3593[Abstract/Free Full Text]
|
| 36.
|
Fridkis-Hareli, M.,
Teitelbaum, D.,
Arnon, R.,
and Sela, M.
(1995)
Cellular Immunology
163,
229-236[CrossRef][Medline]
[Order article via Infotrieve]
|
| 37.
|
Fridkis-Hareli, M.,
Teitelbaum, D.,
Pecht, I.,
Arnon, R.,
and Sela, M.
(1997)
Int. Immunol.
9,
925-934[Abstract/Free Full Text]
|
| 38.
|
Fridkis-Hareli, M.,
Strominger, J. L.,
Mehr, R.,
Perelson, A. S.,
Globerson, A.,
Morecki, S.,
Nabet, C.,
Falk, P.,
Pecht, I.,
Mond, J. J.,
Slavin, S.,
Teitelbaum, D.,
Arnon, R.,
Sela, M.,
Gurevich, E.,
Brautbar, C.,
Kwon, O. J.,
and Brenner, T.
(1998)
J. Immunol.
160,
4386-4397[Abstract/Free Full Text]
|
| 39.
|
Lal, R. B.,
Kumaraswami, V.,
Steel, C.,
and Nutman, T. B.
(1990)
Am. J. Trop. Med. Hyg.
42,
56-64
|
| 40.
|
Harnett, M. M.,
Deehan, M. R.,
Williams, D. M.,
and Harnett, W.
(1998)
Parasite Immunol.
20,
551-563[CrossRef][Medline]
[Order article via Infotrieve]
|
| 41.
|
Lochnit, G.,
Dennis, R. D.,
Ulmer, A. J.,
and Geyer, R.
(1998)
J. Biol. Chem.
273,
466-474[Abstract/Free Full Text]
|
| 42.
|
Deehan, M. R.,
Frame, M. J.,
Parkhouse, R. M.,
Seatter, S. D.,
Reid, S. D.,
Harnett, M. M.,
and Harnett, W.
(1998)
J. Immunol.
160,
2692-2699[Abstract/Free Full Text]
|
| 43.
|
Brubaker, J. O.,
Li, Q.,
Tzianabos, A. O.,
Kasper, D. L.,
and Finberg, R. W.
(1999)
J. Immunol.
162,
2235-2242[Abstract/Free Full Text]
|
Copyright © 2000 by The American Society for Biochemistry and Molecular Biology, Inc.

CiteULike Complore Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
Y.-J. Lu, S. Forte, C. M. Thompson, P. W. Anderson, and R. Malley
Protection against Pneumococcal Colonization and Fatal Pneumonia by a Trivalent Conjugate of a Fusion Protein with the Cell Wall Polysaccharide
Infect. Immun.,
May 1, 2009;
77(5):
2076 - 2083.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
B. A Cobb and D. L Kasper
Characteristics of carbohydrate antigen binding to the presentation protein HLA-DR
Glycobiology,
September 1, 2008;
18(9):
707 - 718.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. Duan, F. Y. Avci, and D. L. Kasper
Microbial carbohydrate depolymerization by antigen-presenting cells: Deamination prior to presentation by the MHCII pathway
PNAS,
April 1, 2008;
105(13):
5183 - 5188.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Gallorini, F. Berti, P. Parente, R. Baronio, S. Aprea, U. D'Oro, M. Pizza, J. L. Telford, and A. Wack
Introduction of Zwitterionic Motifs into Bacterial Polysaccharides Generates TLR2 Agonists Able to Activate APCs
J. Immunol.,
December 15, 2007;
179(12):
8208 - 8215.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
L. S.C. Kreisman, J. H. Friedman, A. Neaga, and B. A. Cobb
Structure and function relations with a T-cell-activating polysaccharide antigen using circular dichroism
Glycobiology,
January 1, 2007;
17(1):
46 - 55.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Q. Wang, R. M. McLoughlin, B. A. Cobb, M. Charrel-Dennis, K. J. Zaleski, D. Golenbock, A. O. Tzianabos, and D. L. Kasper
A bacterial carbohydrate links innate and adaptive responses through Toll-like receptor 2
J. Exp. Med.,
December 25, 2006;
203(13):
2853 - 2863.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. Malley, A. Srivastava, M. Lipsitch, C. M. Thompson, C. Watkins, A. Tzianabos, and P. W. Anderson
Antibody-Independent, Interleukin-17A-Mediated, Cross-Serotype Immunity to Pneumococci in Mice Immunized Intranasally with the Cell Wall Polysaccharide
Infect. Immun.,
April 1, 2006;
74(4):
2187 - 2195.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
B. Ruiz-Perez, D. R. Chung, A. H. Sharpe, H. Yagita, W. M. Kalka-Moll, M. H. Sayegh, D. L. Kasper, and A. O. Tzianabos
Modulation of surgical fibrosis by microbial zwitterionic polysaccharides
PNAS,
November 15, 2005;
102(46):
16753 - 16758.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. L. Stephen, M. Niemeyer, A. O. Tzianabos, M. Kroenke, D. L. Kasper, and W. M. Kalka-Moll
Effect of B7-2 and CD40 Signals from Activated Antigen-Presenting Cells on the Ability of Zwitterionic Polysaccharides To Induce T-Cell Stimulation
Infect. Immun.,
April 1, 2005;
73(4):
2184 - 2189.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
B. Monzavi-Karbassi, P. Luo, F. Jousheghany, M. Torres-Quinones, G. Cunto-Amesty, C. Artaud, and T. Kieber-Emmons
A Mimic of Tumor Rejection Antigen-Associated Carbohydrates Mediates an Antitumor Cellular Response
Cancer Res.,
March 15, 2004;
64(6):
2162 - 2166.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
F. Stingele, B. Corthesy, N. Kusy, S. A. Porcelli, D. L. Kasper, and A. O. Tzianabos
Zwitterionic Polysaccharides Stimulate T Cells with No Preferential V{beta} Usage and Promote Anergy, Resulting in Protection against Experimental Abscess Formation
J. Immunol.,
February 1, 2004;
172(3):
1483 - 1490.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Ngamying, P. Sawanpanyalert, R. Butraporn, J. Nikasri, S.-N. Cho, L. Levy, and P. J. Brennan
Effect of Vaccination with Refined Components of the Organism on Infection of Mice with Mycobacterium leprae
Infect. Immun.,
March 1, 2003;
71(3):
1596 - 1598.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. R. Chung, D. L. Kasper, R. J. Panzo, T. Chtinis, M. J. Grusby, M. H. Sayegh, and A. O. Tzianabos
CD4+ T Cells Mediate Abscess Formation in Intra-abdominal Sepsis by an IL-17-Dependent Mechanism
J. Immunol.,
February 15, 2003;
170(4):
1958 - 1963.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
W. M. Kalka-Moll, A. O. Tzianabos, P. W. Bryant, M. Niemeyer, H. L. Ploegh, and D. L. Kasper
Zwitterionic Polysaccharides Stimulate T Cells by MHC Class II-Dependent Interactions
J. Immunol.,
December 1, 2002;
169(11):
6149 - 6153.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. Y. Wang and M. H. Roehrl
Glycosaminoglycans are a potential cause of rheumatoid arthritis
PNAS,
October 29, 2002;
99(22):
14362 - 14367.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. O. Tzianabos, J. Y. Wang, and J. C. Lee
Structural rationale for the modulation of abscess formation by Staphylococcus aureus capsular polysaccharides
PNAS,
July 19, 2001;
(2001)
161175598.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. J. Coyne, A. O. Tzianabos, B. C. Mallory, V. J. Carey, D. L. Kasper, and L. E. Comstock
Polysaccharide Biosynthesis Locus Required for Virulence of Bacteroides fragilis
Infect. Immun.,
July 1, 2001;
69(7):
4342 - 4350.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
W. M. Kalka-Moll, Y. Wang, L. E. Comstock, S. E. Gonzalez, A. O. Tzianabos, and D. L. Kasper
Immunochemical and Biological Characterization of Three Capsular Polysaccharides from a Single Bacteroides fragilis Strain
Infect. Immun.,
April 1, 2001;
69(4):
2339 - 2344.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Y. Wang, W. M. Kalka-Moll, M. H. Roehrl, and D. L. Kasper
Structural basis of the abscess-modulating polysaccharide A2 from Bacteroides fragilis
PNAS,
December 5, 2000;
97(25):
13478 - 13483.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. O. Tzianabos, A. Chandraker, W. Kalka-Moll, F. Stingele, V. M. Dong, R. W. Finberg, R. Peach, and M. H. Sayegh
Bacterial Pathogens Induce Abscess Formation by CD4+ T-Cell Activation via the CD28-B7-2 Costimulatory Pathway
Infect. Immun.,
December 1, 2000;
68(12):
6650 - 6655.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. O. Tzianabos, J. Y. Wang, and J. C. Lee
Structural rationale for the modulation of abscess formation by Staphylococcus aureus capsular polysaccharides
PNAS,
July 31, 2001;
98(16):
9365 - 9370.
[Abstract]
[Full Text]
[PDF]
|
 |
|
Copyright © 2000 by the American Society for Biochemistry and Molecular Biology.
|
Advertisement
Advertisement
|